SUBSCRIBE
SUBSCRIBE
News   Business

SciClone Pharmaceuticals, Inc. To Report Third Quarter 2006 Results On October 31, 2006

October 19, 2006 | 
1 min read
SAN MATEO, CA -- (MARKET WIRE) -- October 19, 2006 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report third quarter 2006 results and host a conference call on Tuesday, October 31, 2006.
Earnings
MORE ON THIS TOPIC
Business people shaking hand in China.
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
September 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie